Northern Trust
HUMA icon

Northern Trust’s Humacyte HUMA Stock Holding History

Northern Trust’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$743K Buy
1,223,908
+76,998
+7% +$80K ﹤0.01% 3461
2025
Q4 		$1.1M Buy
1,146,910
+115,454
+11% +$163K ﹤0.01% 3324
2025
Q3 		$1.79M Sell
1,031,456
-11,185
-1% -$21.9K ﹤0.01% 3100
2025
Q2 		$2.18M Buy
1,042,641
+117,246
+13% +$225K ﹤0.01% 2936
2025
Q1 		$1.58M Buy
925,395
+24,201
+3% +$90.9K ﹤0.01% 3044
2024
Q4 		$4.55M Buy
901,194
+92,708
+11% +$459K ﹤0.01% 2560
2024
Q3 		$4.4M Buy
808,486
+236,024
+41% +$1.56M ﹤0.01% 2561
2024
Q2 		$2.75M Buy
572,462
+22,717
+4% +$118K ﹤0.01% 2732
2024
Q1 		$1.71M Sell
549,745
-15,362
-3% -$51.7K ﹤0.01% 3048
2023
Q4 		$1.6M Buy
565,107
+46,521
+9% +$119K ﹤0.01% 3110
2023
Q3 		$1.52M Buy
518,586
+18,578
+4% +$61.5K ﹤0.01% 3083
2023
Q2 		$1.43M Buy
500,008
+14,171
+3% +$51.1K ﹤0.01% 3203
2023
Q1 		$1.5M Sell
485,837
-24,065
-5% -$68.4K ﹤0.01% 3068
2022
Q4 		$1.08M Buy
509,902
+274,260
+116% +$833K ﹤0.01% 3229
2022
Q3 		$769K Sell
235,642
-6,747
-3% -$25.9K ﹤0.01% 3377
2022
Q2 		$777K Buy
242,389
+120,300
+99% +$669K ﹤0.01% 3406
2022
Q1 		$862K Sell
122,089
-2,287
-2% -$13.3K ﹤0.01% 3497
2021
Q4 		$901K Buy
+124,376
New +$1.23M ﹤0.01% 3586

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.19B AUM 36.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Northern Trust's HUMA Position: Q1 2026 in Review

Northern Trust increased its Humacyte (HUMA) stake by 6.7% in Q1 2026, buying an estimated $80K and bringing the position to 1,223,908 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #3461.

Northern Trust first reported a position in HUMA in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.55M in Q4 2024. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Northern Trust held 1,223,908 shares of Humacyte worth $743K as of Q1 2026.
  • Northern Trust bought 76,998 Humacyte shares in Q1 2026, an estimated $80K.
  • Humacyte made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3461 holding.
  • Northern Trust first reported a position in Humacyte in Q4 2021 and has held it in 18 quarters since.
  • Northern Trust's Humacyte position peaked at $4.55M in Q4 2024.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.